Lactobacillus reuteri DSM 17938 for managing infant colic: Protocol for an individual participant data meta-analysis

BMJ Open

Volumn 4, Issue 12, 2014, Pages

  Sung, Valerie ^a   Cabana, Michael D ^b   D'Amico, Frank ^c   Deshpande, Girish ^d,e   Dupont, Christophe ^f   Indrio, Flavia ^g   Mentula, Silja ^h   Partty, Anna ⁱ   Savino, Francesco ^j   Szajewska, Hania ^k   Tancredi, Daniel ^l  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUQUESNE UNIVERSITY   (United States)

^d NEPEAN HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g UNIVERSITY OF BARI   (Italy)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

^j REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^k MEDICAL UNIVERSITY OF WARSAW   (Poland)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DSM 17938; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; COLIC; CONTROLLED STUDY; CRYING; DRUG EFFICACY; HUMAN; INFANT; INFANT COLIC; INFANT DISEASE; INFANT FEEDING; INTESTINE FLORA; LACTOBACILLUS REUTERI; MATERNAL NUTRITION; META ANALYSIS; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP TIME; TREATMENT OUTCOME;

COLIC; HUMANS; INFANT; LACTOBACILLUS REUTERI; PROBIOTICS; TREATMENT OUTCOME;

EID: 84920736088     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006475     Document Type: Article

References (36)

1. Lucassen PL, Assendelft WJ, van Eijk JT, et al. Systematic review of the occurrence of infantile colic in the community. Arch Dis Child 2001;84:398-403.
2. McMahon C, Barnett B, Kowalenko N, et al. Postnatal depression, anxiety and unsettled infant behaviour. Aust N Z J Psychiatry 2001;35:581-88.
3. Smart J, Hiscock H. Early infant crying and sleeping problems: a pilot study of impact on parental well-being and parent-endorsed strategies for management. J Paediatr Child Health 2007; 43:284-90.
4. Barr RG, Trent RB, Cross J. Age-related incidence curve of hospitalized Shaken Baby Syndrome cases: convergent evidence for crying as a trigger to shaking. [see comment]. Child Abuse Negl 2006;30:7-16.
5. Lee C, Barr RG, Catherine N, et al. Age-related incidence of publicly reported shaken baby syndrome cases: is crying a trigger for shaking? J Dev Behav Pediatr 2007;28:288-93.
6. Howard CR, Lanphear N, Lanphear BP, et al. Parental responses to infant crying and colic: the effect on breastfeeding duration. Breastfeed Med 2006;1:146-55.
7. Savino F, Castagno E, Bretto R, et al. A prospective 10-year study on children who had severe infantile colic. Acta Paediatr Suppl 2005;94:129-32.
8. Hemmi MH, Wolke D, Schneider S. Associations between problems with crying, sleeping and/or feeding in infancy and long-term behavioural outcomes in childhood: a meta-analysis. Arch Dis Child 2011;96:622-9.
9. Garrison MM, Christakis DA. A systematic review of treatments for infant colic. [see comment]. Pediatrics 2000; 106(1 Pt 2):184-90.
10. Lucassen PL, Assendelft WJ. Systematic review of treatments for infant colic. Pediatrics 2001;108:1047-8.
11. Cohen-Silver J, Ratnapalan S. Management of infantile colic: a review. Clinical Pediatr (Phila) 2009;48:14-17.
12. Lehtonen L, Korvenranta H, Eerola E. Intestinal microflora in colicky and noncolicky infants: bacterial cultures and gas-liquid chromatography. J Pediatr Gastroenterol Nutr 1994; 19:310-14.
13. de Weerth C, Fuentes S, Puylaert P, et al. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 2013;131:e550-8.
14. Mentula S, Tuure T, Koskenala R, et al. Microbial composition and fecal fermentation end products from colicky infants-a probiotic supplementation pilot. Microb Ecol Health Dis 2008;20:37-47.
15. Partty A, Kalliomaki M, Endo A, et al. Compositional development of Bifidobacterium and Lactobacillus microbiota is linked with crying and fussing in early infancy. PLoS One 2012;7:e32495.
16. Rhoads JM, Fatheree NY, Norori J, et al. Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr 2009;155:823-28.e1.
17. Roos S, Dicksved J, Tarasco V, et al. 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS One 2013;8: e56710.
18. Savino F, Bailo E, Oggero R, et al. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr Allergy Immunol 2005;16:72-5.
19. Savino F, Cordisco L, Tarasco V, et al. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr 2009;98:1582-8.
20. Savino F, Cordisco L, Tarasco V, et al. Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infants. BMC Microbiol 2011;11:157.
21. Savino F, Cresi F, Pautasso S, et al. Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 2004;93:825-9.
22. Savino F, Pelle E, Palumeri E, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 2007;119:e124-30.
23. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17 938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010;126:e526-33.
24. Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 2013;162:257-62.
25. Sung V, Hiscock H, Tang M, et al. Treating infant colic with the probiotic Lactobacillus reuteri: a randomised double-blind placebo-controlled trial. Bmj 2014;348:g2107.
26. Dupont C, Rivero M, Grillon C, et al. Alpha-lactalbumin-enriched and probiotic supplemented infant formula in infants with colic: growth and gastrointestinal tolerance. Eur J Clin Nutr 2010; 64:767.
27. metaRegister of Controlled Trials. Registered trials numbers ISRCTN95287767, NCT01067027, NCT01279265, NCT01541046, NCT01017991, NCT00167700, NCT01036243, NCT00893711, NCT01849991. 2014. http://wwwcontrolled-trialscom/mrct/searchhtml (accessed 29 Jul 2014).
28. Berlin JA, Golub RM. Meta-analysis as evidence: building a better pyramid. JAMA 2014;312:603-5.
29. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. Bmj 2010;340:c221.
30. Tugwell P, Knottnerus JA. Advantages of individual patient data analysis in systematic reviews. J Clin Epidemiol 2010;63:233-4.
31. Soll RF. Individual patient meta-analysis in pediatrics. Pediatrics 2011;128:775-6.
32. van Walraven C. Individual patient meta-analysis-rewards and challenges. J Clin Epidemiol 2010;63:235-7.
33. Rowland I, Capurso L, Collins K, et al. Current level of consensus on probiotic science- report of an expert meeting -London,23 November 2009. Gut Microbes 2010;1:436-9.
34. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
35. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12.
36. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol 2008;74:6032-40.